Akso Health Group (AHG) financials: revenue, earnings and cash flow
Fiscal 2017–2026 · from SEC filings · data as of November 13, 2026
Summary
Akso Health’s revenue went from $23M in fiscal 2017 to $14M in fiscal 2026, a decline of about 5.5% a year.
Net income in fiscal 2026 was -$19M, a net margin of -135.0%; the best year in this period was 2018 with $65M.
Free cash flow was -$13M in fiscal 2026 and positive in 3 of the 10 years shown.
Revenue, profit and cash flow by year
Income statement
| Fiscal year | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $14M | $15M | $2M | $13M | $6M | $2M | $7M | $4M | $107M | $23M |
| Gross profit | -$11315 | -$281526 | $122132 | $1M | $605134 | $2M | $7M | -$4M | $107M | $23M |
| Operating income | -$21M | -$166M | -$9M | -$14M | -$3M | -$4M | -$48M | -$7M | $76M | $10M |
| Net income | -$19M | -$135M | -$9M | -$1M | -$17M | -$35M | -$71M | $6M | $65M | $9M |
| EPS (diluted) | $-0.02 | $-0.16 | $-0.01 | $-0.00 | $-0.02 | $-0.04 | $-0.08 | $0.01 | $0.08 | $0.01 |
| R&D | — | — | — | — | $421186 | $441405 | $117942 | $0 | $3M | $2M |
| Revenue growth | −6.4% | +512.1% | −81.7% | +108.9% | +259.6% | −74.6% | +87.1% | −96.5% | +368.0% | — |
Cash flow
| Fiscal year | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$13M | $1M | $1M | -$3M | -$9M | $10M | -$58M | -$2M | $88M | $8M |
| Capital spending | -$1638 | -$154460 | — | — | -$4861 | — | -$200360 | -$7590 | -$456030 | -$287765 |
| Free cash flow | -$13M | $1M | — | — | -$9M | — | -$58M | -$2M | $87M | $8M |
| Dividends paid | — | — | — | — | — | — | — | $20M | $0 | $0 |
| Buybacks | — | — | — | — | — | — | $3M | $1M | — | — |
| Stock-based pay | — | — | — | — | $391625 | $55468 | $347466 | $7M | $2M | $0 |
Balance sheet
| Fiscal year | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash | $170572 | $176M | $85M | $8M | $18M | $15M | $7M | $57M | $133M | $19M |
| Debt | $25132 | $81737 | — | — | — | $10M | $21M | $20M | — | — |
| Equity | $181M | $199M | $138M | $9M | $12M | $17M | $48M | $127M | $140M | $24M |
| Total assets | $190M | $215M | $142M | $20M | $63M | $32M | $80M | $173M | $164M | $28M |
| Shares (diluted) | 857M | 857M | 857M | 857M | 857M | 857M | 857M | 857M | 857M | 857M |
Margins and returns
| Fiscal year | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | -0.1% | -1.9% | 5.1% | 9.6% | 9.6% | 100.0% | 100.0% | -100.2% | 100.0% | 100.0% |
| Operating margin | -149.7% | -1125.4% | -357.8% | -108.2% | -51.7% | -241.7% | -695.7% | -194.6% | 70.7% | 43.2% |
| Net margin | -135.0% | -913.4% | -391.8% | -10.3% | -267.0% | -1984.5% | -1029.7% | 149.7% | 61.1% | 37.4% |
| FCF margin | -92.5% | 6.9% | — | — | -136.8% | — | -845.8% | -47.0% | 81.4% | 34.5% |
| ROIC | -10.3% | -68.0% | -4.9% | -129.2% | -21.0% | -12.3% | -55.2% | -3.9% | 46.4% | 35.8% |
| ROE | -10.3% | -67.8% | -6.8% | -15.6% | -137.2% | -201.6% | -148.0% | 4.4% | 46.8% | 36.5% |
Frequently asked questions
What is Akso Health’s annual revenue?
$14M in fiscal 2026.
How much profit does Akso Health make?
Net income was -$19M in fiscal 2026 (net margin -135.0%).
Is Akso Health’s revenue growing?
No: revenue fell 6.4% in fiscal 2026 compared with the year before.
From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.